Latest Information Update: 02 Sep 1998
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action DNA topoisomerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 02 Sep 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 01 Feb 1995 Preclinical development for HIV infections treatment in USA (Unknown route)